AH HealthTech ApS · Denmark

All Humans Deserve Access to Health Technology.

We build focused health technology that makes complex scientific and human decisions clearer, more accessible and more accountable.

AH Somics is our first official product and is currently at concept / pre-MVP stage.

SAH Somics
First official product
SampleResearch specimen 024
AssaySpatial workflow

Evidence review

Morphology assessment
RNA quality context
Protocol compatibility
Missing data check
Proposed decisionReviewScientist sign-off required
Single-cellSpatialExplainable QC

AH Somics
Single-cell & Spatial Omics Intelligence.

From sample quality to biological insights. AH Somics is being developed to connect pre-assay readiness with downstream single-cell and spatial omics analysis.

Concept / pre-MVP
Before the experiment

Sample readiness

Tissue history, morphology, RNA quality and assay eligibility may live in separate records.

During the assay

Technical interpretation

Run, library and imaging QC require protocol-specific scientific judgement.

After the experiment

Lost provenance

Clustering, annotation and spatial analysis can become disconnected from upstream sample conditions.

Our hypothesis: laboratories need traceable, workflow-wide quality context—not another isolated dashboard.

One quality story,
across the workflow.

AH Somics is designed to connect upstream evidence, assay outcomes and biological interpretation while keeping scientists in control.

01
Input

Sample context

Tissue and cell samples, preparation history and assay metadata.

02
Upstream QC

Readiness review

Morphology, RNA or cell QC and assay-aware checks.

03
Data analysis

Omics outputs

Single-cell and spatial data through supported standard pipelines.

04
Insights

Traceable decisions

A joined quality record that keeps scientific context visible.

Concept architecture. Functions described here are planned and have not yet been implemented.

Start upstream.
Build with evidence.

Phase 1 · MVP focus

Pre-assay readiness review

Traceable, explainable quality decision support using versioned rules and human review.

Inputs

Sample metadata, fixation and storage, H&E assessment, RNA quality or cell preparation metrics.

Checks

Assay-specific rules, missing-data flags, protocol compatibility and reviewer overrides.

Output

Proceed / Review / Hold, evidence links and an exportable decision history.

Initial approach: rules plus human review. No predictive accuracy is claimed before validation.

Phase 2 · Planned extension

Downstream bioinformatics

Build on standard pipelines rather than reinventing them.

Data importMatrix, AnnData, SpatialData and supported vendor outputs.
Analysis QCCells, spots, genes, doublets and technical covariates.
Biological insightClustering, annotation, differential expression and spatial context.

Designed for scientific
accountability.

01

Traceable

Connect sample provenance, preparation, QC evidence and later outcomes to each project.

02

Cross-workflow

Use modular, assay-specific checks and reusable schemas across supported platforms.

03

Human-controlled

Show rationale, sources and uncertainty while scientists retain final sign-off.

The test: novelty remains unproven. Validation must demonstrate reduced review time, stronger decision consistency or another measurable benefit.

A focused B2B research market.

The initial buyer hypothesis centres on laboratory and facility managers responsible for quality, documentation and research workflows.

Core facilities

Shared single-cell and spatial services with repeatable QC needs.

Translational research labs

Teams connecting sample preparation to biological interpretation.

Biotech & pharma R&D

Research groups that need controlled, auditable decision support.

Why Denmark

Denmark offers a concentrated single-cell and spatial research ecosystem for founder-led discovery and local validation before broader Nordic and European expansion.

No institutional partnership, facility endorsement or customer relationship is claimed.

All Humans Deserve Access to Health Technology.

AH HealthTech ApS is a Danish health technology company developing focused digital products at the intersection of life science, decision support and human-centred design.

Mission

Make meaningful health technology clearer and more accessible.

First official product

AH Somics · currently in development.

Based in

Denmark

Let’s build health technology
that deserves trust.

We welcome conversations with core facilities, translational laboratories and scientific workflow experts.

info@ahhealthtech.com